Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

GSK receives grant to advance dermal treatment based on Starpharma's dendrimers

Aug. 22, 2011

Photocross-linked biosynthetic implants provide new tool for soft tissue reconstruction

Aug. 19, 2011

Novel lysophospholipid S1P1 receptor agonists disclosed

Aug. 16, 2011

Stiefel submits NDA for tazarotene foam

Aug. 10, 2011

Sanofi discovers new lysophospholipid S1P1 receptor agonists

Aug. 8, 2011

Phase IIb trial of cell therapy for venous leg ulcers meets endpoints

Aug. 5, 2011

Enrollment initiated in phase II/III study of CF-101

Aug. 2, 2011

R-Tech Ueno amends protocol of its phase I trial in eyelash hypotrichosis

July 25, 2011

Ajinomoto synthesizes novel IL-12 and/or IL-23 production inhibitors

July 25, 2011

Novel histamine H4 receptor antagonists prepared by Palau Pharma

July 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026